Cicero M P, Sharp M M, Gross C A, Kreuzer K N
Departments of Microbiology and Biochemistry, Duke University Medical Center, Durham, North Carolina 27710, USA.
J Bacteriol. 2001 Apr;183(7):2289-97. doi: 10.1128/JB.183.7.2289-2297.2001.
Bacteriophage T4 middle-mode transcription requires two phage-encoded proteins, the MotA transcription factor and AsiA coactivator, along with Escherichia coli RNA polymerase holoenzyme containing the sigma(70) subunit. A motA positive control (pc) mutant, motA-pc1, was used to select for suppressor mutations that alter other proteins in the transcription complex. Separate genetic selections isolated two AsiA mutants (S22F and Q51E) and five sigma(70) mutants (Y571C, Y571H, D570N, L595P, and S604P). All seven suppressor mutants gave partial suppressor phenotypes in vivo as judged by plaque morphology and burst size measurements. The S22F mutant AsiA protein and glutathione S-transferase fusions of the five mutant sigma(70) proteins were purified. All of these mutant proteins allowed normal levels of in vitro transcription when tested with wild-type MotA protein, but they failed to suppress the mutant MotA-pc1 protein in the same assay. The sigma(70) substitutions affected the 4.2 region, which binds the -35 sequence of E. coli promoters. In the presence of E. coli RNA polymerase without T4 proteins, the L595P and S604P substitutions greatly decreased transcription from standard E. coli promoters. This defect could not be explained solely by a disruption in -35 recognition since similar results were obtained with extended -10 promoters. The generalized transcriptional defect of these two mutants correlated with a defect in binding to core RNA polymerase, as judged by immunoprecipitation analysis. The L595P mutant, which was the most defective for in vitro transcription, failed to support E. coli growth.
噬菌体T4的中间模式转录需要两种噬菌体编码的蛋白质,即MotA转录因子和AsiA共激活因子,以及含有σ⁷⁰亚基的大肠杆菌RNA聚合酶全酶。使用motA正调控(pc)突变体motA-pc1来筛选可改变转录复合物中其他蛋白质的抑制突变。通过单独的遗传筛选分离出了两个AsiA突变体(S22F和Q51E)和五个σ⁷⁰突变体(Y571C、Y571H、D570N、L595P和S604P)。通过噬菌斑形态和爆发量测量判断,所有七个抑制突变体在体内均表现出部分抑制表型。纯化了S22F突变体AsiA蛋白和五个突变体σ⁷⁰蛋白与谷胱甘肽S-转移酶的融合蛋白。当用野生型MotA蛋白进行测试时,所有这些突变蛋白在体外转录水平正常,但在相同试验中它们未能抑制突变型MotA-pc1蛋白。σ⁷⁰的替换影响了与大肠杆菌启动子-35序列结合的4.2区域。在没有T4蛋白的大肠杆菌RNA聚合酶存在的情况下,L595P和S604P替换极大地降低了来自标准大肠杆菌启动子的转录。由于在延伸的-10启动子上也获得了类似结果,所以这种缺陷不能仅通过-35识别的破坏来解释。通过免疫沉淀分析判断,这两个突变体的普遍转录缺陷与它们与核心RNA聚合酶结合的缺陷相关。L595P突变体在体外转录方面缺陷最大,无法支持大肠杆菌生长。